China's drug regulator approved Zhejiang Hisun Pharmaceutical's (SHA:600267) letermovir antiviral active ingredient, according to a Tuesday filing with the Shanghai bourse.
The drug is indicated for cytomegalovirus prevention and cure in adults and children weighing 6 kilograms or more.